MEET THE TEAM : UNIVERSITY OF ABERDEEN                               LOUGHBOROUGH UNIVERSITY

Aberdeen Uni
VUMC
VUB
BERGEN
Biomagune
Munster
Imanova
AstraZeneca

LOUGHBOROUGH UNIVERSITY

Centre for Sensing and Imaging Science, School of Science, Loughborough, UK

ABERDEEN UNIVERSITY
Institute of Medical Sciences School of Medicine, Medical Sciences and Nutrition, Aberdeen, UK

Lead Professor Matteo Zanda

Lead Professor Matteo Zanda

Chair in Biomolecular Imaging, Current Director, Centre for Sensing & Imaging Science, Loughborough University. Former Professor of Medical Technologies, Univeristy of Aberdeen.

Expert in bioorganic/medicinal chemistry, drug discovery, molecular imaging, particularly PET; leads an active research group with over 20 years of experience as an academic supervisor and researcher.

Extensive entrepreneurial experience: co-founder and CEO of KemoTech (www.kemotech.it) and Signal Pharma (2012) (www.signal-pharma.com).

Involved in EU projects both as a coordinator and partner since FP5: coordinating IAPP “PET BRAIN” June 2010-May 2014, and Head of Unit in the recently funded H2020-MSCA-ITN-2015 European Joint Doctorates Project “MOGLYNET” Sept 2015 – Aug 2019.

Profile

Professor Alison Murray

Professor Alison Murray

Roland Sutton Chair of Radiology

Director of the Aberdeen Biomedical Imaging Centre (www.abdn.ac.uk/ims/research/abic)

Leads clinical brain imaging research in structural and functional brain imaging correlates of cognitive ageing and dementia.

She has extensive NHS clinical experience of brain imaging in dementia, with around 400 nuclear medicine brain regional cerebral blood flow SPECT/CT studies per annum and receptor studies in movement disorder.

Founding member and executive member of the Scottish Imaging Network: A Platform for Scientific Excellence (SINAPSE) www.sinapse.ac.uk

Professor Andy Welch

Professor Andy Welch

Chair in The Institute for Education in Medical and Dental Sciences

Research focus is on the tomographic radiotracer imaging techniques of  PET and Single Photon Emission Computed Tomography (SPECT) as well as Computed Tomography (CT) in general.

 

Particular interests are in deleloping PET methods to detect changes in brain function; this includes the use of Statistical Parametric Mapping and other statistical tools to detect changes in brain metabolism as measuire with FDG-PET. Current research also involves measuring changes in cardiac metabolism with PET, including developing methods to measure glucose, oxidative and fatty acid metabolism.

Profile

 

 

 

 

Lead Professor Matteo Zanda

Professor of Medical Technologies
Expert in bioorganic/medicinal chemistry, drug discovery, molecular imaging, particularly PET; leads an active research group with over 20 years of experience as an academic supervisor and researcher.
Extensive entrepreneurial experience: co-founder and CEO of KemoTech (www.kemotech.it) and Signal Pharma (2012) (www.signal-pharma.com).

Professor Alison Murray

Roland Sutton Chair of Radiology
Director of the Aberdeen Biomedical Imaging Centre (www.abdn.ac.uk/ims/research/abic)

Leads clinical brain imaging research in structural and functional brain imaging correlates of cognitive ageing and dementia.

She has extensive NHS clinical experience of brain imaging in dementia, with around 400 nuclear medicine brain regional cerebral blood flow SPECT/CT studies per annum and receptor studies in movement disorder.

Founding member and executive member of the Scottish Imaging Network: A Platform for Scientific Excellence (SINAPSE) www.sinapse.ac.uk

Professor Andy Welch

Chair in The Institute for Education in Medical and Dental Sciences
Research focus is on the tomographic radiotracer imaging techniques of Positron Emission Tomography (PET) and Single Photon Emission Computed Tomography (SPECT) as well as Computed Tomography (CT) in general.

Particular interest in the development of novel hardware and software to address specific applications. These include clinical applications, preclinical applications and applications in engineering and geosciences.

Current Research: development of PET methods to detect changes in brain function; measurement of changes in cardiac metabolism with PET.

COLLABORATORS

COLLABORATORS

Teresa Morris

WP6 Lead

Imaging Facilities Co-ordinator for Aberdeen Biomedical Imaging Centre

Activities Co-ordinator for Kosterlitz Centre for Therapeutics

Administrator for Roland Sutton Academic Trust an independently managed charitable trust that supports education and research in radiology which has close links with both the NHS and University.

Dr Sergio Dall’Angelo

ESR Supervisor

PhD in Industrial Chemistry
Research Fellow
Research Interests: Synthetic Organic Chemistry; PET Chemistry; Medicinal Chemistry; Total Synthesis

-

NEWS

PET3D PhD

PhD Ilaria Patruno was...

First PET3D PhD

Markus Artelsmair successfully...

Outreach at CIC BiomaGUNE

25 Students from Tolosako Inmakulada Lanbide...

Dissemination Video Jessica Bridoux

PET imaging and therapy - outline of theranostic...

PET3D Manuscripts published 2018

Synthesis of C-14 Labeled GABAA α2/α3 Selective...

IMPACT Article Published

    Link to ingentaconnect article.   The ESRs...

EVENTS

-

PET3D Final Public Conference 28 May 2020

PET3D  Conference cancelled due to COVID-19...

A market model for PET imaging – Open Symposium 4 April 2019

Expertise line up at International Symposium...

S4- School ‘Preclinical Imaging’ Muenster 4 – 9 Nov. 2018

9th Mouse Imaging Academy (MIA) 05-09 November...

Mid-Term Meeting

08 June  2018 PET3D Mid term meeting  ...

S1 – School on ‘Radiopharmaceutical Development’

27 February - 03 March 2017 PET3D 5-day training...